This is in line with the ability of lenalidomide to induce the cell cycle inhibitors p21WAF1 and p27KIP1 in tumor cell lines, particularly by promoting demethylation of the p21WAF1 gene promoter [25]. Here, CDKN1B is linked to neoplasm.